SK Chemicals Co Ltd (006120):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SK Chemicals Co Ltd (006120) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3436
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance resins which include skybon, chemicals for electronics, skyviva, skynova, skyflex, SK compound, and ecotran. The company offers biomaterials such as ecoprime and ecoplan. It also provides new synthetic and botanical drugs, and vaccines. The company has operations in South Korea, the US, China, Japan, Korea, Germany and Singapore. SK Chemicals is headquartered in Gyeonggi-do, South Korea.

SK Chemicals Co Ltd (006120) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 10
SK Biopharma Enters Into Co-Development Agreement With SK Chemicals For YKP-10811 11
SK Chemicals and International Vaccine Institute Enters into Agreement 12
SK Chemicals Enters Into Co-Development Agreement With DNA Link 13
Licensing Agreements 14
Sanofi Pasteur Enters into Licensing Agreement with SK Chemicals 14
Hikma Pharma Enters into Licensing Agreement with SK Chemicals 15
TheraVida Enters Into Licensing Agreement With SK Chemicals For THVD-201 And THVD-202 16
SK Chemicals Co Ltd – Key Competitors 17
SK Chemicals Co Ltd – Key Employees 18
SK Chemicals Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Product News 21
01/09/2017: AFSTYLA, for Haemophilia A, Receives European Commission Approval 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SK Chemicals Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 10
SK Biopharma Enters Into Co-Development Agreement With SK Chemicals For YKP-10811 11
SK Chemicals and International Vaccine Institute Enters into Agreement 12
SK Chemicals Enters Into Co-Development Agreement With DNA Link 13
Sanofi Pasteur Enters into Licensing Agreement with SK Chemicals 14
Hikma Pharma Enters into Licensing Agreement with SK Chemicals 15
TheraVida Enters Into Licensing Agreement With SK Chemicals For THVD-201 And THVD-202 16
SK Chemicals Co Ltd, Key Competitors 17
SK Chemicals Co Ltd, Key Employees 18
SK Chemicals Co Ltd, Other Locations 19
SK Chemicals Co Ltd, Subsidiaries 19
SK Chemicals Co Ltd, Joint Venture 20

List of Figures
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SK Chemicals Co Ltd (006120):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dhanuka Agritech Ltd (DHANUKA):企業の財務・戦略的SWOT分析
    Summary Dhanuka Agritech Ltd (Dhanuka Agritech) is an agro-chemical products manufacturing company that manufactures and offers agro-chemicals. The company’s products include fertilizers, agro-chemicals, and seeds, among others. Its agro-chemicals comprise insecticides, herbicides, fungicides, and p …
  • ENN Energy Holdings Ltd (2688):企業の財務・戦略的SWOT分析
    ENN Energy Holdings Ltd (2688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • US Foods Holding Corp. (USFD):企業の財務・戦略的SWOT分析
    US Foods Holding Corp. (USFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Global Tungsten & Powders Corp.:企業の戦略・SWOT・財務分析
    Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report Summary Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Natra S.A.:企業の戦略・SWOT・財務情報
    Natra S.A. - Strategy, SWOT and Corporate Finance Report Summary Natra S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Emirates NBD Bank PJSC:企業の戦略・SWOT・財務情報
    Emirates NBD Bank PJSC - Strategy, SWOT and Corporate Finance Report Summary Emirates NBD Bank PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Insulet Corp (PODD):製薬・医療:M&Aディール及び事業提携情報
    Summary Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetic s. Omnipod system consists of a dispos …
  • PetroNeft Resources plc (P8ET):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroNeft Resources Plc (PetroNeft) is an upstream oil and gas company. It carries out exploration, development and production of oil and natural gas. The company mainly focuses on oil rich Western Siberia zone in Russia. PetroNeft’s asset base comprises of 50% interest each in License 61 an …
  • Camel-IDS NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company that develops radio-immunotherapeutic drugs for cancer patients. The company offers developing of compound radiopharmaceutical drugs for treatment of Her2 positive cancer. Its technology platform is based on recombinant, small antigen-bindi …
  • NWS Holdings Limited:企業の戦略・SWOT・財務情報
    NWS Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary NWS Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Telekom Malaysia Bhd (TM):企業の財務・戦略的SWOT分析
    Telekom Malaysia Bhd (TM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ishida Co., Ltd.:企業の戦略・SWOT・財務情報
    Ishida Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ishida Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sompo Japan Nipponkoa Holdings, Inc.:企業の戦略・SWOT・財務情報
    Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Abbott Diabetes Care Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company’s products include glucose monitor …
  • Crown Holdings Inc:戦略・SWOT・企業財務分析
    Crown Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Crown Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • WestWind Energy Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary WestWind Energy Pty Ltd (West Wind) is a renewable energy company that offers development, construction, operation and management of wind farms and other energy projects. The company provides energy consultation, planning, and maintenance services. It also operates and maintains wind turbine …
  • NEXTracker Inc:電力:M&Aディール及び事業提携情報
    Summary NEXTracker Inc (NEXTracker), a subsidiary of Flex Ltd, is a renewable energy company. The company is engaged in the design, development, and manufacture of single-axis solar trackers for the power plants. It offers services such as design and engineering, project management, installation, pe …
  • Innovation Pharmaceuticals Inc (IPIX):医療機器:M&Aディール及び事業提携情報
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp, is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company provides pipeline products such as kevetr …
  • Alkermes Plc (ALKS)-製薬・医療分野:企業M&A・提携分析
    Summary Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for the treatment of central nervous system (CNS) diseases. The company’s proprietary products include Aristada, an extended-release intramuscular injectable suspen …
  • Heron Resources Ltd:企業の戦略・SWOT・財務情報
    Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆